These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2945499)

  • 21. Comparison of peripheral and central effects of single and repeated oral dose administrations of bilastine, a new H1 antihistamine: a dose-range study in healthy volunteers with hydroxyzine and placebo as control treatments.
    García-Gea C; Martínez-Colomer J; Antonijoan RM; Valiente R; Barbanoj MJ
    J Clin Psychopharmacol; 2008 Dec; 28(6):675-85. PubMed ID: 19011437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of terbutaline and bambuterol on immediate-type allergic skin responses and mediator release in human skin.
    Petersen LJ; Skov PS
    Inflamm Res; 2003 Sep; 52(9):372-7. PubMed ID: 14504664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioavailability of two oral formulations of loratadine 20 mg with concomitant ketoconazole: an open-label, randomized, two-period crossover comparison in healthy Mexican adult volunteers.
    Piñeyro-López A; Pineyro-Garza E; Torres-Alanís O; Reyes-Araiza R; Gómez Silva M; Wacksman N; Lujàn Rangel R; de Lago A; Trejo D; Gonzàlez-de la Parra M; Namur S
    Clin Ther; 2006 Jan; 28(1):110-5. PubMed ID: 16490584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model.
    Deschamps C; Dubruc C; Mentre F; Rosenzweig P
    Clin Pharmacol Ther; 2000 Dec; 68(6):647-57. PubMed ID: 11180025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of acrivastine and terfenadine on skin reactivity to histamine.
    Leynadier F; Murrieta M; Dry J; Colin JN; Gillotin C; Steru D
    Ann Allergy; 1994 Jun; 72(6):520-4. PubMed ID: 7911286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effect of Phlai capsules on skin test responses among allergic rhinitis patients: a randomized, three-way crossover study.
    Tanticharoenwiwat P; Kulalert P; Dechatiwongse Na Ayudhya T; Koontongkaew S; Jiratchariyakul W; Soawakontha R; Booncong P; Poachanukoon O
    J Integr Med; 2017 Nov; 15(6):462-468. PubMed ID: 29103416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Inhibition of histamine-induced wheal, flare and doppler laser flowmetry during long-term (180 days) of cetirizine 10 mg per day treatment].
    Kruszewski J; Kłos K; Sułek K
    Pol Merkur Lekarski; 2005 Dec; 19(114):758-60. PubMed ID: 16521417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis.
    Ratner PH; van Bavel JH; Martin BG; Hampel FC; Howland WC; Rogenes PR; Westlund RE; Bowers BW; Cook CK
    J Fam Pract; 1998 Aug; 47(2):118-25. PubMed ID: 9722799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of loratadine (Sch-29851): a new non-sedating antihistamine in seasonal allergic rhinitis.
    Dockhorn RJ; Bergner A; Connell JT; Falliers CJ; Grabiec SV; Weiler JM; Shellenberger MK
    Ann Allergy; 1987 Jun; 58(6):407-11. PubMed ID: 2954497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of the skin reaction to histamine by ebastine.
    Nelson HS; Bucher B; Buchmeier A; Oppenheimer J; Garcia J
    Ann Allergy Asthma Immunol; 1995 May; 74(5):442-7. PubMed ID: 7749977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of dermographia, histamine, and dextromethorphan skin tests by ketotifen. A possible effect on cutaneous vascular response to mediators.
    Mansfield LE; Taistra P; Santamauro J; Ting S; Andriano K
    Ann Allergy; 1989 Sep; 63(3):201-6. PubMed ID: 2774302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histamine wheal and flare inhibition by clemastine fumarate.
    Burns RB; Shelanski MV
    Ann Allergy; 1977 May; 38(5):339-44. PubMed ID: 324322
    [No Abstract]   [Full Text] [Related]  

  • 36. Tachyphylaxis to histamine-induced wheal suppression by topical 0.05% clobetasol propionate in normal versus croton oil-induced dermatitic skin.
    Singh S; Gupta A; Pandey SS; Singh G
    Dermatology; 1996; 193(2):121-3. PubMed ID: 8884147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of on-site and photographic evaluations of the suppressive effects of cetirizine, loratadine, and fexofenadine on skin response to histamine lontophoresis: A double-blind, crossover study in healthy volunteers.
    Tsuda H; Takiwaki H
    Curr Ther Res Clin Exp; 2005 Jul; 66(4):307-22. PubMed ID: 24672131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tachyphylaxis to topical steroid measured by histamine-induced wheal suppression.
    Singh G; Singh PK
    Int J Dermatol; 1986 Jun; 25(5):324-6. PubMed ID: 3721670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of subsensitivity to loratadine during long-term dosing during 12 weeks.
    Bousquet J; Chanal I; Skassa-Brociek W; Lemonier C; Michel FB
    J Allergy Clin Immunol; 1990 Aug; 86(2):248-53. PubMed ID: 1974561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the CNS properties of SCH 29851, a potential non-sedating antihistamine.
    Barnett A; Iorio LC; Kreutner W; Tozzi S; Ahn HS; Gulbenkian A
    Agents Actions; 1984 Jun; 14(5-6):590-7. PubMed ID: 6236679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.